` SONA (Sona Nanotech Inc) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

S
SONA
vs
S
S&P TSX Composite Index (Canada)

Over the past 12 months, SONA has significantly outperformed S&P TSX Composite Index (Canada), delivering a return of +92% compared to the S&P TSX Composite Index (Canada)'s +25% growth.

Stocks Performance
SONA vs S&P TSX Composite Index (Canada)

Loading
SONA
S&P TSX Composite Index (Canada)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SONA vs S&P TSX Composite Index (Canada)

Loading
SONA
S&P TSX Composite Index (Canada)
Difference
www.alphaspread.com

Performance By Year
SONA vs S&P TSX Composite Index (Canada)

Loading
SONA
S&P TSX Composite Index (Canada)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Sona Nanotech Inc vs Peers

S&P TSX Composite Index (Canada)
SONA
0KHE
TMO
DHR
LONN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Sona Nanotech Inc
Glance View

Sona Nanotech, Inc. is a nanotechnology life sciences company, which engages in the development and manufacture of rod-shaped gold nanoparticles. The company is headquartered in Halifax, Nova Scotia and currently employs 8 full-time employees. The company went IPO on 2018-10-04. The firm is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its core technology is a rod-shaped nanoparticle manufactured at scale with surfactants that allow the production of two different product lines (Gemini and Omni) for use in both in-vitro and in-vivo applications, such as lateral flow diagnostics and cell imaging respectively. The firm's gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The firm also offers development services to help lateral flow producers create new lateral flow tests and improve existing tests for their product iteration.

SONA Intrinsic Value
Not Available
S
Back to Top